Investing.com - Array BioPharma Inc (NASDAQ:ARRY) experienced a sell-off during Wednesday’s after hours session. Shares were down 7% in after hours trade, after gaining 5.6% in the regular session. Driving the movement in shares of the biopharmaceutical company was its announcement that it would undertake a public offering for $175 million in common stock.